Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Jourdan

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Oncogene|April 24, 2002
Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cellsYue Dan Wang, John De Vos, Michel Jourdan, et al.
Blood|October 25, 2003
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosisKarène Mahtouk, Michel Jourdan, John De Vos, et al.
European Cytokine Network|April 6, 2005
Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factorsMichel Jourdan, Karène Mahtouk, Jean-Luc Veyrune, et al.
Plos One|June 22, 2017
Characterization of human FCRL4-positive B cellsMichel Jourdan, Nicolas Robert, Maïlys Cren, et al.
International Journal of Hematology|September 5, 2003
Survival and proliferation factors of normal and malignant plasma cellsBernard Klein, Karin Tarte, Michel Jourdan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applicationsKarène Mahtouk, Dirk Hose, John De Vos, et al.
British Journal of Haematology|February 3, 2009
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cellsMichel Jourdan, Thierry Reme, Hartmut Goldschmidt, et al.
Blood|October 23, 2009
An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterizationMichel Jourdan, Anouk Caraux, John De Vos, et al.
BMC Cancer|May 15, 2010
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarraysKarène Mahtouk, Jérôme Moreaux, Dirk Hose, et al.
Human Gene Therapy|December 13, 2003
Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cellsJohn De Vos, Claude Bagnis, Lydie Bonnafoux, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Oncogene|April 24, 2002
Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cellsYue Dan Wang, John De Vos, Michel Jourdan, et al.
Blood|October 25, 2003
An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosisKarène Mahtouk, Michel Jourdan, John De Vos, et al.
European Cytokine Network|April 6, 2005
Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factorsMichel Jourdan, Karène Mahtouk, Jean-Luc Veyrune, et al.
Plos One|June 22, 2017
Characterization of human FCRL4-positive B cellsMichel Jourdan, Nicolas Robert, Maïlys Cren, et al.
International Journal of Hematology|September 5, 2003
Survival and proliferation factors of normal and malignant plasma cellsBernard Klein, Karin Tarte, Michel Jourdan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applicationsKarène Mahtouk, Dirk Hose, John De Vos, et al.
British Journal of Haematology|February 3, 2009
Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cellsMichel Jourdan, Thierry Reme, Hartmut Goldschmidt, et al.
Blood|October 23, 2009
An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterizationMichel Jourdan, Anouk Caraux, John De Vos, et al.
BMC Cancer|May 15, 2010
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarraysKarène Mahtouk, Jérôme Moreaux, Dirk Hose, et al.
Human Gene Therapy|December 13, 2003
Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cellsJohn De Vos, Claude Bagnis, Lydie Bonnafoux, et al.
Pageof 4